One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for ...

Is the U.S. getting the best return on investment (ROI) for its NIH buck? That’s the basic question at the heart of a white paper Sen. Bill Cassidy (R-La.) issued May 9 to continue a conversation he ...

AC Immune SA has landed a potential $2.2 billion deal for its anti-amyloid beta Alzheimer’s disease vaccine, ACI-24.060, with Takeda Pharmaceutical Co. Ltd., under which it will get $100 million up ...

Researchers from the University of Florida have developed a novel mRNA cancer vaccine that aims to reprogram the immune system to target and attack cancer cells effectively. The study led by Elias ...

The U.S. FDA’s final rule for lab-developed tests was a long time in coming even if the agency shorted the public comment ...

A licensing deal worth potentially up to $1.2 billion with Sanofi SA has breathed new life into Novavax Inc., which has ...

Researchers from the Icahn School of Medicine at Mount Sinai and affiliated organizations presented the discovery and ...

Angle plc recently signed an agreement with Astrazeneca plc to develop an androgen receptor (AR) detection assay for use in ...

Avicenna Biosciences Inc. has introduced an extension to its machine learning (ML) technology platform to enhance medicinal ...

Recent findings discovered a mutation in the METTL23 gene, which encodes methyltransferase-like protein 23, in a pedigree of ...

As the average cost of new drug R&D continues to skyrocket, the perception around using artificial intelligence (AI) as a ...

In a research collaboration that could bring in up to $600 million, Metaphore Biotechnologies Inc. has become the third ...